Drug Class
antibody-drug conjugate
Type
brand
Active Ingredient
sacituzumab
Educational overview only. This page summarizes publicly available information about Trodelvy for general understanding. For full prescribing details, consult official labeling or a healthcare professional.
📋Overview
Trodelvy is a type of targeted therapy called an antibody-drug conjugate. It is composed of a monoclonal antibody that is chemically linked to a chemotherapy drug.
The antibody portion of the medication is designed to recognize and attach to specific proteins on the surface of cancer cells. Once attached, the medication enters the cell and releases the chemotherapy component to help stop the growth and spread of the cancer.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Trodelvy
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.
